INTRODUCTION
Thrombin is a multi-functional serine proteinase that regulates the growth characteristics, morphology and biochemistry of a variety of mammalian cell types involved in haemostasis and wound healing. It can, for example, activate blood platelets [1, 2] , act as a mitogen for fibroblasts or lymphocytes [3, 4] and macrophages [5] , and evoke several responses in endothelial cells [6] [7] [8] . However, it also influences the behaviour of other cells, inhibiting neurite outgrowth from cultured neuronal cells [9] [10] [11] and stimulating bone resorption [12] [13] [14] .
It is possible that all of these cellular responses to thrombin are mediated through the recently cloned thrombin receptor [15, 16] . This molecule, a novel member of the 'seven-span' superfamily of G-protein-coupled receptors, comprises seven transmembrane domains, a C-terminal cytoplasmic tail and a long N-terminal extracellular region which contains a thrombin recognition site [15, 16] . Binding of thrombin is thought to provoke a change in receptor conformation [17] , followed by thrombin-catalysed cleavage to release a 41-residue N-terminal peptide. The new Nterminus then functions as a tethered agonistic ligand that activates the receptor, and thus initiates cellular responses to thrombin stimulation. This model of receptor activation is confirmed by the observation that peptides which mimic the new N-terminal sequence can duplicate most of the cellular effects of thrombin [18] [19] [20] [21] .
Considerable information is available on the biochemical consequences of thrombin receptor activation, but understanding cellular Ca2+ concentration, similar to those produced by low concentrations of thrombin, after -30 min. We conclude that prothrombin-and thrombin-induced neurite retractions are not dependent on PtdIns(4,5)P2 and Ca2+ mobilization, but are more probably mediated through an effector mechanism involving protein tyrosine kinase activation. No intracellular Ca2+ mobilization, protein tyrosine kinase activity or neurite retraction was observed after treatment of cells with proteolytically inactive mutant thrombin (S205 -+ A). Prothrombin-mediated intracellular Ca2+ mobilization and neurite retraction were inhibited by hirudin, which was shown to interact with thrombin but not prothrombin. It is concluded that cleavage of prothrombin to thrombin is a necessary prerequisite for biological activity on differentiated Adl2ElHER1O cells and that differences in agonist concentration are capable of coupling the thrombin receptor to different pathways within the cell.
of the mechanisms by which the tethered N-terminal ligand stimulates the various responses of target cells remains incomplete. Receptor stimulation causes both increased activity of phosphoinositidase C and pertussis-toxin-sensitive inhibition of adenylate cyclase [22, 23] , with the 1,2-diacyglycerol and Ins(1,4,5)P3 formed by phosphoinositidase C then stimulating protein kinase C and mobilizing intracellular Ca2l stores [24] . Thrombin also stimulates tyrosine kinase activity [25] [26] [27] [28] [29] , activates mitogen-activated protein (MAP) kinases [30] and increases GTP binding to Ras [31, 32] . The inter-relationships between these responses are still not clear, but it is now apparent that stimulation of thrombin receptors does not always produce exactly the same pattern of biochemical response and does not always lead to increased DNA synthesis and mitogenesis.
This heterogeneity of responses is particularly evident in experiments that compare cellular responses to thrombin and to synthetic peptides that mimic the effects of the receptor-tethered ligand. For example, treatment of hamster fibroblasts with thrombin gives rise to a prolonged activation of MAP kinase, whereas the receptor peptide SFLLRNP produces only a transient increase in activity [30] . Moreover, a peptide ligand with a single amino acid substitution can act as a partial agonist that causes a shape change of human platelets, but provokes no Ca2+ mobilization, protein kinase C activation, secretion or aggregation [33] . It [9, [34] [35] [36] [37] . It is presumed that regulation by thrombin comes into play when a trauma to the central nervous system compromises the blood-brain barrier and activates thrombin formation. Such trauma is, of course, not essential for the normal regulation ofneuronal cell differentiation, and prothrombin, which is the proenzyme precursor of thrombin and an abundant plasma protein, also induces neurite retraction both in primary cultures of human neuroepithelial cells and in the transformed human cell line Adl2ElHER10 [38, 39] . The likelihood that prothrombin is a biologically relevant regulator of neurite outgrowth is greatly enhanced by the fact that the responsive cells themselves express prothrombin mRNA [40] . Previous results have suggested that prothrombin's action requires its conversion to thrombin at the surface of responsive cells, followed by activation of the thrombin receptor [39] .
We have now undertaken a much more extensive examination of the action of prothrombin on differentiated neuronal cells, in particular by comparing the abilities of thrombin and prothrombin to provoke several different responses [neurite retraction, protein tyrosine phosphorylation, phosphoinositide breakdown, phosphoinositide 3-kinase (PI3K) activation and intracellular Ca2+ mobilization]. The results confirm that for cells to respond to prothrombin it must be converted to thrombin, and they also indicate some notable quantitative differences in the relative sensitivities ofdifferent responses to these two stimuli.
MATERIALS AND METHODS Cells Adl2E1HER10 cells were produced by transfection of human embryo retinoblasts (HERs) with adenovirus early region 1 (El) DNA [41] . Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 8% fetal calf serum (FCS) and 2 mM glutamine in plastic tissue culture dishes. Cells were differentiated by treatment with 2 mM dibutyryl cyclic AMP (dbcAMP) in supplemented serum-free DMEM [42] . Additional dbcAMP was added every second day to maintain the differentiated phenotype.
For neurite retraction assays, Adl2E1HER10 cells were plated at low density in 5 cm plastic tissue culture dishes and differentiated for 2 days. Reversal of differentiation was initiated by the addition of thrombin or prothrombin (both obtained from Calbiochem). The number of neuritic processes (with a length in excess of two cell bodies) was then counted directly (i.e. without fixing) for four sets of 50 cells at each time point.
Mutant thrombin (Ser to Ala at residue 205) which has no proteolytic activity was expressed in baby hamster kidney cells and purified by immunoaffinity chromatography using an antibody which recognizes human prothrombin.
Assays of thrombin activity
The proteolytic activities of the enzyme and proenzyme were assayed using a synthetic substrate (Channel Diagnostics) essentially as described previously [39] . [44] . Radioactivity in the eluate was monitored, and 3H-labelled inositol phosphates were identified by comparison of their elution characteristics with those of 3H-labelled standards (Amersham).
P13K assays Cells stimulated with thrombin or prothrombin were lysed in icecold lysis buffer (137 mM NaCl, 2.7 mM KCl, 1.0 mM MgCl2, 1 .0 mM CaCl2, 0.5 mM Na4VO3, 1 % Nonidet P-40, 10 % glycerol, 20 mM Tris/HCl, pH 8.0, 10 ,ll/ml leupeptin and 2 mM PMSF). p85oc was immunoprecipitated from cell lysates, using monoclonal antibody (mAb) U13 Protein tyrosine phosphorylation in Adl2E1HER10 cells Cells were grown in 5 cm plastic tissue culture dishes and differentiated by the addition of dbcAMP in serum-free defined medium on day 1 and day 3. Experiments were performed on day 4. Cells were treated with thrombin, mutant thrombin, prothrombin or FCS for the appropriate times. Reactions were stopped by removing the medium containing the stimulating molecule followed by briefly rinsing with ice-cold saline containing 0.4 mM sodium vanadate, 1O mM NaF and 1O mM sodium pyrophosphate. A 300 ,1 aliquot of 9 M urea containing 50 mM Tris/HCl, pH 7.4, 0.15 M ,-mercaptoethanol, 0.4 mM sodium vanadate and 10 mM NaF was added, and the samples were sonicated and stored at -20 'C. Aliquots (50 ,ug of protein) were fractionated on polyacrylamide gels (12 %) and then transferred to nitrocellulose filters which were incubated with an anti-phosphotyrosine monoclonal antibody (UBI). Tyrosinephosphorylated proteins were visualized using the ECL protocol (Amersham). Di-isopropylfluorophosphate-modified thrombin (DIP-thrombin) and DIP-prothrombin were prepared by the method described previously [38] .
RESULTS
Response of differenUated Ad12E1HER10 cells to thrombin and prothrombin It has previously been shown that Adl2E1HER1O cells serve as an excellent model for the differentiation of human neuroepithelial cells [38, 39, 42] . Addition of dbcAMP, in the absence of FCS, produces a differentiated phenotype exemplified by 'rounded up' cell bodies and the extension of neuritic-type processes (compare Figures la and Ib). Differentiation can be reversed by FCS, thrombin or prothrombin [38] . To assess the relative abilities ofthe latter two proteins to produce a phenotypic change, Ad12E1HER1O cells were differentiated for 2 days and the proportion of cells in which reversal of differentiation occurred was measured (as neurite retraction at various times after addition of the agonists). Examples of agonist-treated cultures are presented in Figure 1 , and the time courses of neurite retraction in response to different doses of prothrombin and thrombin are shown in Figure 2 . Thrombin was considerably more potent in this assay, higher concentrations of prothrombin being required to return cells to the undifferentiated phenotype. Neurite retraction occurred in about half of the responsive cells after treatment with 2 nM prothrombin for -30 min, whereas 3 pM thrombin produced a similar response in half that time (Figure 2 ). Prothrombin at < 1 nM had relatively little effect. The observed responses to prothrombin tended to vary between experiments rather more than with thrombin, giving rise to artefactual plateaus seen in some of the curves in Figure 2(b) .
However, the overall sensitivities of neurite retraction to prothrombin were reproducible in different experiments. While the It seems likely that the absence of detectable Ins(1,4,5)P3 formation in response to prothrombin reflects the inability of our assays to detect the formation of the small concentrations of Ins(1,4,5)P3 needed to initiate Ca2+ oscillations, rather than the complete absence of Ins(1,4,5)P3. It has previously been suggested that the action of Ins(1,4,5)P3 is highly co-operative and that very low concentrations are needed to open a few Ca21 channels [51] .
Both thrombin (10 nM) and prothrombin (10 nM) caused a rapid but transient accumulation of the predominant InsP5 isomer (Figure 6 ), which was likely to be Ins (1,3,4 Figure 7 Thrombin-and prothrombin-lnduced changes in P13K activity in differentiated Ad12E1HER1O cells Differentiated Ad12E1HER10 cells were stimulated with either 10 nM thrombin (Thr) or 10 nM prothrombin (Pro), harvested after the allotted times and then subjected to immunoprecipitation using the monoclonal antibody Ul 3, directed against the p85a subunit of P13K. After incubation with Ptdlns and Mg2+ATP, lipids were separated on Whatman LK6D TLC plates. Radioactive spots were detected by autoradiography, eluted from the plate and radioactivity was counted.
We therefore compared the relative activities of prothrombin and thrombin in stimulating protein tyrosine phosphorylation. Phosphorylation was detected by Western blotting of cell extracts using an antibody which recognized tyrosine phosphate residues. After addition of thrombin (25 pM), there was rapid phosphorylation of three major proteins of molecular mass 62, 100 and 200 kDa ( Figure 8a) ; the phosphorylation of other, less prominent, bands became apparent after prolonged stimulation. Addition of prothrombin at concentrations (5 nM) which caused rapid neurite retraction but no initial Ca2+ mobilization produced a pattern of protein phosphorylation similar to that seen with thrombin (Figure 8b ), although modification of some bands became apparent at later times: for example, phosphorylation of the 62 kDa protein was seen after 2 min with thrombin but only after 25 min with prothrombin. The most prominent bands seen after Western blotting were similar to those reported previously [24, 28] . In addition to the bands that were phosphorylated in response to stimulation, a 60 kDa protein already phosphorylated in differentiated Adl2E1HER10 cells (marked with an arrow in Figures 8a and 8b ) rapidly became dephosphorylated in response to thrombin and prothrombin.
Modification of thrombin with DIP blocks its active site and abolishes its proteolytic and mitogenic activity, whereas incubation of prothrombin with DIP produces no change in its ability to cause neurite retraction [38] . Addition of DIP-modified proteins to differentiated cells produced effects consistent with there being a requirement for prothrombin to be converted to thrombin in order to stimulate tyrosine phosphorylation: DIPthrombin caused little increase in protein phosphorylation, whereas there was virtually no difference between DIP-treated prothrombin and the native protein (Figures 8a and 8b) .
Similarly, the addition of proteolytically inactive mutant thrombin (7 nM) caused no change in the pattern of protein tyrosine phosphorylation (results not shown). Addition of genistein (20,M) to differentiated Adl2ElHER10 cells prior to stimulation with thrombin or prothrombin reduced but did not abolish tyrosine phosphorylation, and also reduced the ability of thrombin and prothrombin to induce neurite retraction (results not shown).
Cell-mediated conversion of prothrombin to thrombin
Previous studies have suggested that small amounts of free thrombin may be formed during treatment of differentiated Adl2ElHER10 cells with prothrombin [39] . This phenomenon has been examined using a chromogenic proteinase assay. Incubation of prothrombin with Adl2ElHER10 cells at 37°C for 1 h in DMEM resulted in conversion of at least a fraction of the prothrombin to thrombin (Figure 9) . If, however, incubations were carried out in PBS (results not shown) or in medium containing EDTA ( Figure 9 ) the prothrombin remained inactive; addition of Ca2l and Mg2+ restored the proteolytic activity ( Figure 9 ). Addition of prothrombin to differentiated cells in PBS rather than in DMEM did not result in neurite retraction. We conclude, therefore, that bivalent cations are essential for the cell-mediated conversion of prothrombin to thrombin, and that this conversion is necessary for the prothrombin-mediated morphological changes associated with neurite retraction.
Interaction of hirudin with thrombin and prothrombin
To confirm that the attenuation of the mobilization of intracellular Ca2+ after addition of hirudin to prothrombin was due to complex formation between the polypeptide and newly formed thrombin rather than direct binding to the proenzyme, the interaction of hirudin with the two proteins was compared. It can be seen from the autoradiograph presented in Figure 10 that when a mixture of prothrombin and 125I-hirudin was immunoprecipitated with an antibody which recognized pro--(a) Using purified reagents we have now shown that appreciably higher concentrations ofprothrombin than thrombin are required to produce a similar morphological response ( [38, 39] ; Figures 1  and 2 ). It has already been demonstrated that this activity is attributable to the protein itself and is not due to initial contamination by thrombin [38, 39] . However, it has always seemed likely that cleavage of prothrombin would be required before the protein could become biologically active. Indeed, preliminary results have tended to suggest this, as the biological activity of prothrombin can be inhibited by glia-derived nexin, a specific inhibitor of thrombin [39] . In view of these data, it might be expected that prothrombin would elicit similar biochemical responses to those seen with thrombin, although perhaps slightly more slowly. The results presented in the present paper, however, show that this view is an over-simplification, and there appear to be distinct differences between the two agonists. The data presented here confirm previous observations [22, 23, 30] that stimulation of the thrombin receptor in neuroepithelial cells by thrombin ( in a limited number of cells would pass undetected using the currently available methods. It is important, however, to note that both agonists were capable of inducing morphological changes at concentrations far lower than those required for the release of Ca2+.
Since no agonist-generated Ins(1,4,5,)P3 was observed, and it is likely that the response to thrombin has a similar mechanism, the elevation of Ins(1,3,4,5,6)PJ after stimulation with prothrombin presumably arose from InsP6 dephosphorylation. InsP6 has been shown in vitro to be dephosphorylated to a number of InsP5 isomers [including Ins (1, 3, 4, 5, 6 )P5] by an inositol polyphosphate phosphatase that was originally detected as Ins(1,3,4,5)P4 3-phosphatase [54] . Activation of this enzyme has previously been reported during thrombin stimulation of human platelets [55] .
Stimulation of the production of PtdIns(3,4,5)P3 by a PtdIns(4,5)P2-directed P13K activity is provoked both by receptor tyrosine kinases and by some agonists, including thrombin, which utilize heterotrimeric G-proteins to couple surface stimulation to phosphoinositidase C-fl-directed PtdIns(4,5)P2 hydrolysis (see, for example, Stephens et al. [58] ). Both thrombin and prothrombin produced a rapid stimulation of P13K activity, but it is not clear at present whether this kinase activation is mediated by tyrosine phosphorylation or through a direct Gprotein-dependent mechanism, nor how significant this activation is for the morphological changes associated with reversal of differentiation. The observation that prothrombin is able to induce changes in InsP5 and InsPl metabolism and PI3K activity suggests that these processes would be sensitive to very low demonstrated that they occur at agonist concentrations lower than those required for calcium mobilization but sufficient to induce neurite retraction. Additionally, it has not been shown unequivocally that InsPJ dephosphorylation and P13K activation are the same at very low concentrations of prothrombin and thrombin, although we have no reason to believe that this should not be so.
There is no doubt that thrombin and prothrombin both cause rapid increases in tyrosine phosphorylation of a similar set of polypeptides (Figure 8) , consistent with the idea that both stimuli employ a similar (or the same) receptor. Additionally, the speed of this tyrosine phosphorylation is such that it could be involved in the regulation of neurite retraction (caused by thrombin and prothrombin). Similarly, the concentrations of agonists required to induce both neurite retraction and protein tyrosine phosphorylation are comparable, both processes being triggered by 25 pM thrombin and 2 nM prothrombin, at which concentrations no Ca2l mobilization occurred.
The observation that prothrombin-induced neurite retraction and Ca2l mobilization were inhibited by hirudin strongly suggests that the conversion of prothrombin to thrombin is essential for its biological activity when added to Adl2ElHER1O cells. The co-immunoprecipitation data presented in Figure 10 confirmed that hirudin failed to bind to prothrombin and was therefore very unlikely to inhibit an activity which was not reliant on cleavage to thrombin. Similarly, prothrombin was found to exhibit no activity in neurite-retraction assays in the presence of EDTA, another condition under which cell-mediated conversion to thrombin is inhibited ( Figure 9 ). These data are consistent with our previous report that glia-derived nexin could inhibit neurite retraction [39] , and very recent evidence which suggests that a novel proteinase capable of activating prothrombin exists on the surface of certain cell types [60] . Additional, although indirect, evidence that proteolytic activity derived from prothrombin is essential for its biological activity is provided by our demonstrations that proteolytically inactive mutant thrombin was unable to cause neurite retraction, Ca2+ mobilization or protein tyrosine phosphorylation. The obvious conclusion from these results is that simple binding to the cell surface by thrombin is insufficient to cause stimulation, and therefore that cleavage of the thrombin receptor is essential. By implication, binding of prothrombin to the cell surface is unlikely to trigger the observed responses. These conclusions are consistent with the observations that the thrombin receptor activating peptide (TRAP-508) [61] has no activity when added to differentiated Adl2ElHERO0 cells (T. R. V. Pagliuca and R. J. A. Grand, unpublished work).
Previous studies have implied that not all of the observed cellular responses to thrombin are mediated through the cloned receptor [22, 23, 30] . However, the data presented have clearly demonstrated that different agonist concentrations can give rise to alternative intracellular responses. Thus, very low levels of thrombin added or generated from prothrombin by cells in the presence of bivalent cations are sufficient to activate protein tyrosine kinases and induce neurite retraction, and possibly to generate InsP, and activate P13K. At higher concentrations of either thrombin or prothrombin Ca2+ is mobilized, probably following phosphoinositidase C activation, InsP, is generated and P13K is activated. At very high concentrations of thrombin (which are never generated by cellular conversion of prothrombin) phosphoinositidase C is activated to such an extent that sufficient Ins(1,4,5)P, is produced to cause a rapid synchronized release of intracellular Ca2+. This hypothesis is supported by recent evidence which demonstrates that differences in extracellular thrombin concentrations produce different rates of concentrations of thrombin, although it has not been definitively receptor activation which then govem the cells' response [62] 
